SURMOUNT-5: Tirzepatide −20.2% vs Semaglutide −13.7%. TRIUMPH-1 (retatrutide) just reported: -28.3%. Read this before the cross-trial comparison. 🇺🇸 $LLY 🇩🇰 $NVO $NOVO www.midgardfinance.com/blog/2026/05... #GLP1 #Obesity #Retatrutide

1 likes 0 replies